tirzepatide vs semaglutide trial Tirzepatide: Head-to-Head for Weight Loss & Diabetes Tirzepatide vs Semaglutide 2026: 22%

Before administering Zepbound, a prescription drug manufactured by Eli Lilly and Company, its vital to understand the correct procedures to ensure effective and safe injection

In December, the FDA released a statement to health care professionals and patients warning against the use of compounded and counterfeit versions of diabetes and obesity drugs, including semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly)

Some weight regain is expected without continued lifestyle support

For the 17mg/mL concentration, 2.5mg equals approximately 14.7 units (0.147 mL)

These conditions are associated with an increased risk of thyroid carcinoma and MEN 2 syndrome when using GLP-1 medications